openPR Logo
Press release

Drugs of Abuse Testing Market Size 2013 to 2017 and Forecast 2018 to 2024

04-26-2018 03:43 PM CET | Health & Medicine

Press release from: Precision Business Insights

Drugs of Abuse Testing Market

Drugs of Abuse Testing Market

Global Drugs of Abuse Testing Market: Drug (Narcotic, Sedatives, Psychostimulants, Hallucinogens, Others), End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers), Test Type (Chromatography, Immunoassay, Rapid Testing), Sample (Hair, Saliva, Urine, Others), End User (Diagnostic Centers, Forensic Labs, Hospitals) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Drugs of Abuse Testing market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

Market Outline: Drugs of Abuse Testing Market
Drugs of Abuse Testing is used to determine one or more prescription or illegal drugs that present in the biological samples of a patient. Drugs of abuse are the illicit drugs that are taken for non-medical purposes.

Market Dynamics: Drugs of Abuse Testing Market
Technological advancements of analyzers, rise in availability of forbidden drugs, increase in emphasis on work place screening propels the market growth of drugs of abuse testing market. Furthermore, rise in number of clinical laboratories offering tests for drugs of abuse, increase in demand for drug of abuse testing from private employers also drives the market for drug of abuse testing market globally. However, unfavorable reimbursement policies, low threshold of drug abuse testing laws in emerging countries may hamper the growth of the drug of abuse testing market globally.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/drugs-of-abuse-testing-market/#ulp-4H8Z4LpNMLEuOnnx


Market Scope: Drugs of Abuse Testing Market
Drugs of Abuse Testing market is segmented based on the Drug, Test Type, Sample, End User and geographical regions
Based on the Drug, the market is segmented into the following:
• Narcotic
• Sedatives
• Psychostimulants
• Hallucinogens
• Others
Based on the Test Type, the market is segmented into the following:
• Chromatography
• Immunoassay
• Rapid Testing
Based on the Sample, the market is segmented into the following:
• Hair
• Saliva
• Urine
• Others
Based on the End User, the market is segmented into the following:
• Diagnostic Centers
• Forensic Labs
• Hospitals
Based on the Geographical Regions, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/drugs-of-abuse-testing-market/#ulp-c654SbFYO64MsOhu

Market Summary: Drugs of Abuse Testing Market
Currently, drug abusing is a major problem which is negatively impacting huge population globally. People who are addicted to alcohol or who are prescribed with prolonged usage of drugs are more prone to chronic diseases which are prevailing among global population that leads to economic burden on the nation. Hence, governments across the world are actively taking part in various initiatives to create awareness among people regarding prevention, eradication and early detection of drug abuse. However, companies are focusing on new product launches, minimizing the price of the tests in order to gain maximum traction in the global market. Furthermore, market players are concentrating on various growth strategies such as collaborations, acquisitions, partnerships to enhance their market presence.

Regional Analysis: Drugs of Abuse Testing Market
Geographically, global Drugs of Abuse Testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds largest position in Drugs of Abuse Testing market globally especially U.S followed by European countries owing to the increase in availability of illicit drugs, rise in drug trafficking etc. As per to the National Institute of Drug Abuse, around 24.6 Mn Americans with age above 12 years used illicit drug. Asia Pacific, Latin America and MEA regions are also anticipated to have lucrative growth in Drugs of Abuse Testing market owing to the economic instability, un organized government regulations, lack of awareness regarding the usage of drugs, less literacy rates compared to developed countries, increase in adoption of western lifestyle etc.
.
Competition Assessment: Drugs of Abuse Testing Market
Some of the players in the global Drugs of Abuse Testing market include:
• Siemens Healthineers (Germany)
• Thermo Fisher Scientific Inc. (U.S.)
• Drägerwerk AG & Co. KGaA, (Germany)
• Hoffmann-La Roche Ltd. (Switzerland)
• Danaher Corporation (Beckman Coulter, Inc.) (U.S.)
• Laboratory Corporation of America Holdings (U.S.)
• Abbott Laboratories (U.S.)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/drugs-of-abuse-testing-market/#ulp-14mlyhjMGhVjZqa3


Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/drugs-of-abuse-testing-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drugs of Abuse Testing Market Size 2013 to 2017 and Forecast 2018 to 2024 here

News-ID: 1032239 • Views:

More Releases from Precision Business Insights

Biochar Market Growth Is Attributed To The Increased Production Of Biochar Through Pyrolysis Technology
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Membrane Separation Technology
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Generation
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug